Consumer-Law Records

Price v. Diab confirms ADA plaintiffs can secure fee awards even via default judgment, and Holmes v. Bax shows ADA claims often survive summary judgment, but neither involves retail website accessibility specifically, limiting direct applicability.

ADA claims were affirmed in Holmes v. Bax and the underlying ADA violation/default judgment was upheld in Price v. Diab, showing courts often find liability, but Price v. Diab also reversed fee entitlement and Holmes vacated the injunction remedy, signaling remedy-stage risk even after liability is found.

None of the cited comparables involve false advertising against a footwear/apparel brand; closest analogs (Citizens of Humanity 'Made in USA' case, Premier Nutrition) show mixed outcomes from full dismissal to $90M settlement. Survival hinges on N.D. Cal.'s typically strict Rule 9(b)/reasonable-consumer pleading standard.

Minano v. DLJ shows several FCRA furnisher theories dismissed for no private right of action, while Askins v. CRST held bare statutory disclosure violations confer standing and can survive. Outcomes for Equifax-specific furnisher claims are split depending on which FCRA subsection is pled.

ADA claims fared well on merits in Holmes v. Bax (affirmed) but fee-shifting outcomes are inconsistent, as Price v. Diab reversed a fee award despite a favorable injunction. No case here directly addresses accessibility merits for a retail defendant like Bradshaw Taylor.

ADA claims survived/affirmed in Holmes v. Bax and fee entitlement was recognized in Price v. Diab, suggesting courts are receptive to ADA accessibility theories, but neither involves website/facility accessibility against a small developer like Fryd.

Only two comparables directly touch ADA (Price v. Diab on fee-shifting after default judgment; Holmes v. Bax affirming ADA violations), both showing courts readily find liability once facts are established, but neither involves a website-accessibility fact pattern like Bop, LLC likely faces.

ADA accessibility claims often survive motions to dismiss (Holmes v. Bax affirmed ADA violations at summary judgment), but Title III suits yield no damages—only injunctive relief and fees (Price v. Diab). Small-business defendant with unclear entity identity adds uncertainty.

ADA accessibility claims generally survive motions to dismiss per Holmes v. Bax's affirmance of ADA violations, and Price v. Diab shows plaintiffs can secure default judgments/fees even against small defendants.

Comparables are mostly off-theory (ECOA, SNAP, wage claims); only Price v. Diab and Holmes v. Bax involve ADA and both favored plaintiffs, suggesting courts are receptive to ADA claims surviving early stages.

No comparables directly involve false advertising against a small regional defendant; closest analogues (Citizens of Humanity 'Made in USA' labeling, Guthrie UCL, Cetorelli CSPA) show mixed outcomes ranging from affirmed dismissal to affirmed liability. LineaFlexo appears to be a small Pompano Beach automotive business, not a national brand, so mega-settlement comparables are likely inapplicable.

False advertising claims often survive early motions when specific labeling misrepresentations are pled (Dougherty MTD granted only in part), but class-wide relief can stall on individualized reliance issues as in Guthrie's affirmed denial of certification. Small-sample comparables show wide variance from dismissal to nine-figure settlements.

False advertising claims against auto makers face mixed outcomes: Olson v. FCA US was affirmed but underlying disposition unclear, while comparable consumer-fraud rulings (Guthrie, Citizens of Humanity) show courts scrutinizing individualized reliance and probable cause closely. Settlement data shows large aggregate recoveries but wide variance ($90M-$586M) reflecting case-specific facts.

Tracking-tech privacy claims split: Bayhealth found a duty of confidentiality survived MTD, while Integris saw state privacy claims deemed 'unclear' and federal officer removal rejected; Gunnar Optiks shows pleadings-stage dismissals are often premature and vacated on appeal.

Rulings split: Bayhealth allowed confidentiality claims from tracking tech to survive, while Integris saw privacy-sharing claims called 'unclear' and Gunnar's BIPA claim was remanded for fact development rather than resolved. No clean pharma-wiretap precedent yet decides this exact fact pattern.

Comparable privacy rulings split: Bayhealth survived a confidentiality claim while LabCorp and Integris saw claims dismissed or narrowed on technical grounds; wiretap claims against a regional utility lack a close factual analog to the big-tech settlements cited.

Comparable privacy/tracking rulings split: Bayhealth found a duty of confidentiality survives MTD, while Integris and LabCorp left claims 'unclear' pending fact development. Gunnar Optiks shows even facially strong statutory claims often survive only on remand, not outright win, signaling fact-intensive early litigation.

Comparable pixel/tracking rulings split: Doe v. Bayhealth allowed breach-of-confidentiality claims to survive while Integris Health left state privacy claims 'unclear' after removal fight, and Clements v. Gunnar Optiks needed factual development before surviving. No single ruling clearly forecasts outcome for BI's wiretap theory.

Tracking-technology privacy claims against healthcare-adjacent defendants have split outcomes: Bayhealth's confidentiality claim survived MTD, while Integris left state privacy claims unclear and Gunnar Optiks required factual development rather than dismissal. No wiretap ruling here is squarely favorable, reflecting genuine doctrinal uncertainty on pixel/tracking claims.

Comparable healthcare-tracking-tech rulings split: Bayhealth allowed breach-of-confidentiality claims to survive while Integris left state privacy claims unclear and Gunnar Optiks required factual development before dismissal could stick. Six prior filings against this same defendant suggest a coordinated wave of pixel/tracker claims, increasing scrutiny but also settlement pressure.

Similar tracking-tech privacy claims split: Doe v. Bayhealth let a confidentiality claim survive while Doe v. Integris found state-law tracking claims 'unclear' and rejected federal officer removal. Six parallel filings against BI suggest a coordinated wave typical of pixel/session-replay suits with uneven early outcomes.

Comparable rulings split: Doe v. Bayhealth allowed a confidentiality claim over tracking tech to survive, and Clements v. Gunnar Optiks (BIPA) was revived on remand, but LabCorp and Integris show courts often narrow or dismiss related privacy theories on procedural/technical grounds. Six near-identical filings against BI suggest a coordinated wiretap/pixel-tracking theory that could survive early motions but faces fact-intensive defenses.

Comparable privacy-tracking rulings split: Doe v. Bayhealth allowed breach-of-confidentiality claims to survive MTD, and Gunnar Optiks survived on remand, but Integris shows state law privacy claims often remain 'unclear' pending factual development. Six prior filings against BI suggest a recurring pixel/tracking theory facing similar mixed outcomes.

Doe v. Bayhealth shows confidentiality/tracking-tech claims can survive MTD, and Gunnar Optiks shows courts often defer dismissal pending factual development on tracking tech; but Integris Health shows privacy claims sometimes remain 'unclear' post-remand and jurisdictional fights persist.

Similar health-privacy tracking-tech claims split: Doe v. Bayhealth survived on breach-of-confidentiality theory, while Doe v. Integris saw state privacy claims remanded as 'unclear' and Gunnar Optiks required factual development before dismissal could stand.